Company profile TFFP
There is not enough data for developing inhaled dry powder drugs to provide analysis
There is not enough data for developing inhaled dry powder drugs to provide correlation calculation
There is not enough data for developing inhaled dry powder drugs to provide analysis
There is not enough data for TFF Voriconazole Inhalation Powder to provide analysis
There is not enough data for TFF Voriconazole Inhalation Powder to provide correlation calculation
There is not enough data for TFF Voriconazole Inhalation Powder to provide analysis
There is not enough data for TFF Tacrolimus Inhalation Powder to provide analysis
There is not enough data for TFF Tacrolimus Inhalation Powder to provide correlation calculation
There is not enough data for TFF Tacrolimus Inhalation Powder to provide analysis
There is not enough data for Augmenta monoclonal antibodies to provide analysis
There is not enough data for Augmenta monoclonal antibodies to provide correlation calculation
There is not enough data for Augmenta monoclonal antibodies to provide analysis
There is not enough data for TFF Niclosamide to provide analysis
There is not enough data for TFF Niclosamide to provide correlation calculation
There is not enough data for TFF Niclosamide to provide analysis
After 34 days of this quarter the interest is at 103.0. Based on that we can calculate that during remaining 58 days it will total up to 279.0. vaccines expected interest is significantly higher compared to previous quarter (+48.4%) and same quarter last year (+53.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 64 |
| 2019 | 168 162.5% QoQ | 150 -10.7% QoQ | 101 -32.7% QoQ | 105 64.1% YoY 4.0% QoQ |
| 2020 | 128 -23.8% YoY 21.9% QoQ | 151 0.7% YoY 18.0% QoQ | 148 46.5% YoY -2.0% QoQ | 312 197.1% YoY 110.8% QoQ |
| 2021 | 862 573.4% YoY 176.3% QoQ | 601 298.0% YoY -30.3% QoQ | 598 304.1% YoY -0.5% QoQ | 438 40.4% YoY -26.8% QoQ |
| 2022 | 247 -71.3% YoY -43.6% QoQ | 160 -73.4% YoY -35.2% QoQ | 174 -70.9% YoY 8.8% QoQ | 182 -58.4% YoY 4.6% QoQ |
| 2023 | 125 -49.4% YoY -31.3% QoQ | 148 -7.5% YoY 18.4% QoQ | 188 8.0% YoY 27.0% QoQ | 103 -43.4% YoY -45.2% QoQ |
The average 5 years interest of vaccines was 19.74 per week. The last year interest of vaccines compared to the last 5 years has changed by -36.68%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 24.5%.
There is not enough data for University of Texas at Austin license agreement to provide analysis
There is not enough data for University of Texas at Austin license agreement to provide correlation calculation
There is not enough data for University of Texas at Austin license agreement to provide analysis
There is not enough data for Augmenta Bioworks joint development agreement to provide analysis
There is not enough data for Augmenta Bioworks joint development agreement to provide correlation calculation
There is not enough data for Augmenta Bioworks joint development agreement to provide analysis
There is not enough data for UNION therapeutics A/S licensing and collaboration agreement to provide analysis
There is not enough data for UNION therapeutics A/S licensing and collaboration agreement to provide correlation calculation
There is not enough data for UNION therapeutics A/S licensing and collaboration agreement to provide analysis
There is not enough data for National Institute of Environmental Health Sciences collaborative research and development agreement to provide analysis
There is not enough data for National Institute of Environmental Health Sciences collaborative research and development agreement to provide correlation calculation
There is not enough data for National Institute of Environmental Health Sciences collaborative research and development agreement to provide analysis
After 38 days of this quarter the interest is at 25.0. Based on that we can calculate that during remaining 53 days it will total up to 60.0. invasive pulmonary aspergillosis expected interest is significantly higher compared to same quarter last year (+inf%) but lower than previous quarter (-67.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 41 inf% QoQ | 183 346.3% QoQ | 102 -44.3% QoQ |
| 2020 | 93 inf% YoY -8.8% QoQ | 57 39.0% YoY -38.7% QoQ | 245 33.9% YoY 329.8% QoQ | 28 -72.5% YoY -88.6% QoQ |
| 2021 | 201 116.1% YoY 617.9% QoQ | 157 175.4% YoY -21.9% QoQ | 177 -27.8% YoY 12.7% QoQ | 176 528.6% YoY -0.6% QoQ |
| 2022 | 184 -8.5% YoY 4.5% QoQ | 93 -40.8% YoY -49.5% QoQ | 66 -62.7% YoY -29.0% QoQ | 180 2.3% YoY 172.7% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 234 151.6% YoY inf% QoQ | 31 -53.0% YoY -86.8% QoQ | 187 3.9% YoY 503.2% QoQ |
| 2024 | 25 inf% YoY -86.6% QoQ | - | - | - |
The average 5 years interest of invasive pulmonary aspergillosis was 9.46 per week. The last year interest of invasive pulmonary aspergillosis compared to the last 5 years has changed by -3.07%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 23.25%.
After 38 days of this quarter the interest is at 53.0. Based on that we can calculate that during remaining 53 days it will total up to 127.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 80 | 216 170.0% QoQ | 214 -0.9% QoQ | 269 25.7% QoQ |
| 2020 | 171 113.8% YoY -36.4% QoQ | 109 -49.5% YoY -36.3% QoQ | 196 -8.4% YoY 79.8% QoQ | 284 5.6% YoY 44.9% QoQ |
| 2021 | 190 11.1% YoY -33.1% QoQ | 144 32.1% YoY -24.2% QoQ | 239 21.9% YoY 66.0% QoQ | 278 -2.1% YoY 16.3% QoQ |
| 2022 | 179 -5.8% YoY -35.6% QoQ | 159 10.4% YoY -11.2% QoQ | 144 -39.7% YoY -9.4% QoQ | 189 -32.0% YoY 31.2% QoQ |
| 2023 | 175 -2.2% YoY -7.4% QoQ | 208 30.8% YoY 18.9% QoQ | 220 52.8% YoY 5.8% QoQ | 208 10.1% YoY -5.5% QoQ |
| 2024 | 53 -69.7% YoY -74.5% QoQ | - | - | - |
The average 5 years interest of lung transplant rejection was 15.1 per week. The last year interest of lung transplant rejection compared to the last 5 years has changed by 4.44%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -4.54%.
After 38 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 53 days it will total up to 98.0. COVID-19 therapeutics expected interest is significantly higher compared to previous quarter (+250.0%) and same quarter last year (+1125.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 30 | 0 -100.0% QoQ | 49 inf% QoQ | 41 -16.3% QoQ |
| 2020 | 248 726.7% YoY 504.9% QoQ | 468 inf% YoY 88.7% QoQ | 319 551.0% YoY -31.8% QoQ | 239 482.9% YoY -25.1% QoQ |
| 2021 | 225 -9.3% YoY -5.9% QoQ | 114 -75.6% YoY -49.3% QoQ | 209 -34.5% YoY 83.3% QoQ | 148 -38.1% YoY -29.2% QoQ |
| 2022 | 207 -8.0% YoY 39.9% QoQ | 130 14.0% YoY -37.2% QoQ | 99 -52.6% YoY -23.8% QoQ | 99 -33.1% YoY 0.0% QoQ |
| 2023 | 8 -96.1% YoY -91.9% QoQ | 65 -50.0% YoY 712.5% QoQ | 46 -53.5% YoY -29.2% QoQ | 28 -71.7% YoY -39.1% QoQ |
| 2024 | 41 412.5% YoY 46.4% QoQ | - | - | - |
The average 5 years interest of COVID-19 therapeutics was 10.82 per week. The last year interest of COVID-19 therapeutics compared to the last 5 years has changed by -66.54%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 16.77%.
After 38 days of this quarter the interest is at 32.0. Based on that we can calculate that during remaining 53 days it will total up to 77.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 13 inf% QoQ | 5 -61.5% QoQ | 2 -60.0% QoQ |
| 2020 | 411 inf% YoY 20450.0% QoQ | 592 4453.8% YoY 44.0% QoQ | 356 7020.0% YoY -39.9% QoQ | 293 14550.0% YoY -17.7% QoQ |
| 2021 | 300 -27.0% YoY 2.4% QoQ | 235 -60.3% YoY -21.7% QoQ | 252 -29.2% YoY 7.2% QoQ | 172 -41.3% YoY -31.7% QoQ |
| 2022 | 191 -36.3% YoY 11.0% QoQ | 157 -33.2% YoY -17.8% QoQ | 126 -50.0% YoY -19.7% QoQ | 116 -32.6% YoY -7.9% QoQ |
| 2023 | 103 -46.1% YoY -11.2% QoQ | 79 -49.7% YoY -23.3% QoQ | 64 -49.2% YoY -19.0% QoQ | 89 -23.3% YoY 39.1% QoQ |
| 2024 | 32 -68.9% YoY -64.0% QoQ | - | - | - |
The average 5 years interest of COVID-19 disease was 13.8 per week. The last year interest of COVID-19 disease compared to the last 5 years has changed by -53.99%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1571.05%.
There is not enough data for pulmonary diseases and conditions. to provide analysis
There is not enough data for pulmonary diseases and conditions. to provide correlation calculation
There is not enough data for pulmonary diseases and conditions. to provide analysis